UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
6-K
REPORT
OF FOREIGN PRIVATE ISSUER
PURSUANT
TO RULE 13a-16 OR 15d-16
UNDER
THE SECURITIES EXCHANGE ACT OF 1934
For
the Month of: September 2025
Commission
File Number: 001-38428
PolyPid
Ltd.
(Translation
of registrant’s name into English)
18
Hasivim Street
Petach
Tikva 495376, Israel
(Address
of principal executive office)
Indicate by check
mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:
☒ Form
20-F ☐ Form 40-F
CONTENTS
Attached
hereto and incorporated herein is PolyPid Ltd.’s (the “Registrant”) press release issued on September 16, 2025, titled
“PolyPid Successfully Completes Israeli Ministry of Health GMP Inspection, Advancing Towards Commercial Manufacturing Readiness
for D-PLEX₁₀₀.”
The
first, second and the fourth paragraphs and the section titled “Forward-looking Statements”
in the press release are incorporated by reference into the Company’s registration statements on Form F-3 (File No. 333-276826,
File No. 333-280658,
File No. 333-281863,
File No. 333-284376 and
File No. 333-289034) and Form S-8 (File No. 333-239517,
File No. 333-271060, File
No. 333-277703, File No. 333-280662
and File No. 333-289570) filed with the Securities and Exchange Commission to be a part thereof from the date on which this report is
submitted, to the extent not superseded by documents or reports subsequently filed or furnished.
EXHIBIT INDEX
| Exhibit No. |
|
|
| 99.1 |
|
Press release issued by PolyPid Ltd. on September 16, 2025, titled “PolyPid Successfully Completes Israeli Ministry of Health GMP Inspection, Advancing Towards Commercial Manufacturing Readiness for D-PLEX₁₀₀.” |
SIGNATURES
Pursuant to the
requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned,
thereunto duly authorized.
| |
POLYPID
LTD. |
| |
|
|
| Date: September 16, 2025 |
By: |
/s/
Dikla Czaczkes Akselbrad |
| |
|
Name: |
Dikla Czaczkes
Akselbrad |
| |
|
Title: |
Chief Executive Officer |
3
